0001567619-19-000660.txt : 20190107
0001567619-19-000660.hdr.sgml : 20190107
20190107120841
ACCESSION NUMBER: 0001567619-19-000660
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190101
FILED AS OF DATE: 20190107
DATE AS OF CHANGE: 20190107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baldasare Bryan T
CENTRAL INDEX KEY: 0001761920
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14902
FILM NUMBER: 19512769
MAIL ADDRESS:
STREET 1: 3471 RIVER HILLS DRIVE
CITY: CINCINNATI
STATE: OH
ZIP: 45244
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC
CENTRAL INDEX KEY: 0000794172
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 310888197
STATE OF INCORPORATION: OH
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 3471 RIVER HILLS DR
CITY: CINCINNATI
STATE: OH
ZIP: 45244
BUSINESS PHONE: 5132713700
MAIL ADDRESS:
STREET 1: 3471 RIVER HILLS DRIVE
CITY: CINCINNATI
STATE: OH
ZIP: 45244
FORMER COMPANY:
FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC
DATE OF NAME CHANGE: 19920703
3
1
doc1.xml
FORM 3
X0206
3
2019-01-01
0
0000794172
MERIDIAN BIOSCIENCE INC
VIVO
0001761920
Baldasare Bryan T
3471 RIVER HILLS DRIVE
CINCINNATI
OH
45244
0
1
0
0
Chief Accounting Officer
Common Stock
30871
D
Stock Option (Right to Buy)
19.71
2020-08-04
Common Stock
1500
D
Stock Option (Right to Buy)
19.56
2026-03-24
Common Stock
15000
D
These non-qualified options were awarded under the 2004 Equity Compensation Plan and are fully vested and exercisable.
These non-qualified options were awarded under the 2012 Stock Incentive Plan and vest in four equal installments from the date of grant (i.e., vest 25% per year until fully vested on March 24, 2020)
/s/ F. Mark Reuter as Attorney-in-Fact for Bryan T. Baldasare
2019-01-07